GlassScriptPhysician profile
Laura L Kramer
NPI 1407977499
$498.64
in general payments reported to CMS, 2019-2025
9 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $75.95 · 2023: $18.36 · 2024: $40.71 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $104.83 | 2025 | Reactiv8 |
| Abbott Laboratories | $100.79 | 2025 | Proclaim |
| Organon LLC | $75.95 | 2022 | |
| Boston Scientific Corporation | $74.47 | 2025 | General - Pain Management |
| Sanofi Pasteur INC. | $40.05 | 2023-2024 | |
| Stryker Corporation | $36.56 | 2025 | Mild Device Kit |
| Saluda Medical Americas, INC. | $28.56 | 2025 | Evoke |
| Merck Sharp & Dohme LLC | $19.02 | 2024 | Vaxneuvance, Gardasil, Gardasil 9 |
| Curonix LLC | $18.41 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.